These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 7007844)
1. [Antilipemic drugs]. Schwandt P Med Monatsschr Pharm; 1980 Oct; 3(10):302-5. PubMed ID: 7007844 [No Abstract] [Full Text] [Related]
2. [Evaluation of the effects of tiadenol in various types of dyslipidemia]. Saettone G; Cazzani E; Romanò M; Muzio L Clin Ter; 1982 May; 101(4):387-93. PubMed ID: 7105643 [No Abstract] [Full Text] [Related]
3. [Hyperlipidemia: physiopathology and our experience in the ambulatory care of 3 groups of patients undergoing blood lipid normalization treatment]. Cigala O; della Valle M; Pancallo MT; Marasco A; Malarbi A Clin Ter; 1991 Jan; 136(1):11-21. PubMed ID: 1826868 [TBL] [Abstract][Full Text] [Related]
4. [Drugs in hyperlipidemia]. Stuyt PM Ned Tijdschr Geneeskd; 1987 Sep; 131(36):1554-8. PubMed ID: 3670435 [No Abstract] [Full Text] [Related]
5. [Dyslipoproteinemia of diabetes: fibrates or statins?]. Moulin P Diabetes Metab; 1999 Sep; 25(3):270-4. PubMed ID: 10499198 [No Abstract] [Full Text] [Related]
7. [Clinical experimentation of clofibride. Apropos of 40 cases]. Warembourg H; Jaillard J Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928 [No Abstract] [Full Text] [Related]
8. [Therapeutic trial of a normolipemic agent: ethanolamine N-oxy-nicotinate]. Warembourg H; Ketelers JY; Ginestet A Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1331-5. PubMed ID: 4608970 [No Abstract] [Full Text] [Related]
9. [Clinical trials with Fonlipol. Apropos of 50 cases]. Warembourg H; Jaillard J Lille Med; 1974 Apr; 19(4 Suppl 11):528-31. PubMed ID: 4612282 [No Abstract] [Full Text] [Related]
10. The effect on serum tocopherol levels of drug-induced decrease in serum lipids. Weiss P; Bianchine JR Am J Med Sci; 1969 Oct; 258(4):275-81. PubMed ID: 5823464 [No Abstract] [Full Text] [Related]
11. [Clinical trial of tibric acid, a new hypolipidemic agent]. Noseda G; Sirtori CR Schweiz Med Wochenschr; 1974 Dec; 104(51):1917-22. PubMed ID: 4438990 [No Abstract] [Full Text] [Related]
12. [Drug therapy of dyslipidemias]. Fonda M; Cattin L; Guarnieri G Recenti Prog Med; 2000; 91(7-8):375-8. PubMed ID: 10932924 [No Abstract] [Full Text] [Related]
13. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)]. Fourrier A; Mouton Y Lille Med; 1974 Apr; 19(4 Suppl 11):532-7. PubMed ID: 4612283 [No Abstract] [Full Text] [Related]
14. [Hypolipemic effects of 1-10(hydroxy-2 ethylthio) decane (LL1558), based on 77 cases of essential hyperlipidemia]. Rouffy J; Loeper J Therapie; 1972; 27(3):433-44. PubMed ID: 4570211 [No Abstract] [Full Text] [Related]